← All trials
NCT05000294
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 3, 2021
- Primary completion
- Jun 30, 2023
- Completion date
- Jun 30, 2024
- First posted
- Aug 11, 2021
- Last posted
- Nov 16, 2021
- Enrollment
- 29
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of FloridaLead sponsor
- University of FloridaOverall official - principal investigator
- GenentechCollaborator
- AVEO PharmaceuticalsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.